Abstract
In this Research Highlight, we discuss an exceptionally elegant and far-reaching study from the Arpaia lab at Columbia University, who have engineered a probiotic Escherichia coli strain to eliminate cancer.
| Original language | English |
|---|---|
| Pages (from-to) | 1-4 |
| Number of pages | 4 |
| Journal | Immunology and Cell Biology |
| Volume | 103 |
| Issue number | 1 |
| DOIs |
|
| Publication status | Published - 5 Jan 2025 |